http://www.fpnotebook.com/
N-Acetylcysteine
Aka: N-Acetylcysteine, Acetadote, Mucomyst
- Indications: Established
- Acetaminophen Overdose
- Contrast-Induced Nephropathy prevention
- Indications: Evolving
- Prevention of COPD Exacerbation
- Dose: 600-1200 mg/day in divided dosing
- Decramer (2005) Lancet 365(9470):1552-60
- Idiopathic Pulmonary Fibrosis
- Dose: 1800 mg/day in divided dosing
- Demedts (2005) N Engl J Med 353(21):2229-42
- Mechanism
- N-Acetylcysteine increases glutathione levels
- Acts as detoxification agent
- Acts as antioxidant
- N-Acetylcysteine increases nitric oxide concentrations
- Stimulates vasodilation
- Adverse Effects (uncommon at doses 1200 mg/day or less)
- Nausea
- Vomiting
- Diarrhea
- Dosing: Acetaminophen Overdose
- As directed by Rumack-Matthew Acetaminophen nomogram
- http://www.ars-informatica.ca/toxicity_nomogram.php?calc=acetamin
- Adults
- Oral
- Load: 140 mg/kg orally for 1 dose
- Next 70 mg/kg every 4 hours for total of 17 doses
- IV
- Load: 150 mg/kg IV for 1 dose
- Next: 12.5 mg/kg/hour for 4 hours
- Next: 6.25 mg/kg/hour for 16 hours
- Child
- Oral: Same as for adults
- IV: Same as for adults EXCEPT for <88 lb (40 kg), dilute to 40 mg/ml in D5W
- Smaller volume to prevent Hyponatremia
- References
- Rowden (2006) Clin Lab Med 26(1): 49-65
- Sung (1997) Pediatrics 100(3 pt 1): 389-91